U.S. patent application number 17/003251 was filed with the patent office on 2021-03-04 for systems and methods addressing multiple aspects to provide a comprehensive recovery program for addictions, chronic conditions and diseases.
This patent application is currently assigned to Buffalo Pacific LLC. The applicant listed for this patent is David Lee Allen, Josette Marie Allen, Peter McDuffie White. Invention is credited to David Lee Allen, Josette Marie Allen, Peter McDuffie White.
Application Number | 20210059943 17/003251 |
Document ID | / |
Family ID | 1000005103131 |
Filed Date | 2021-03-04 |
United States Patent
Application |
20210059943 |
Kind Code |
A1 |
Allen; David Lee ; et
al. |
March 4, 2021 |
Systems and methods addressing multiple aspects to provide a
comprehensive recovery program for addictions, chronic conditions
and diseases
Abstract
A comprehensive addiction treatment method with a medication
delivery system of subcutaneous implant micro-pellets in a
horizontal orientation parallel to Langer lines in the horizontal
plane surrounding the upper hips and lower back in patients, which
may include a method of identification at an advanced video
communication system through facial recognition, voice recognition
and/or a recognition of an RFID microchip implanted in a patient.
The identification will be transmitted over the Internet to a
database at a secure server to initiate a computer program to
stream video content, computer generated communication and/or a
live video to be transmitted to an audio-visual system that may be
capable of displaying a life-size video image of a live caregiver
or a computer generated avatar of a caregiver within a three
dimensional setting for real time two-way communication with
apparent eye contact.
Inventors: |
Allen; David Lee; (Union,
OH) ; Allen; Josette Marie; (Union, OH) ;
White; Peter McDuffie; (Bonham, TX) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Allen; David Lee
Allen; Josette Marie
White; Peter McDuffie |
Union
Union
Bonham |
OH
OH
TX |
US
US
US |
|
|
Assignee: |
Buffalo Pacific LLC
Englewood
OH
|
Family ID: |
1000005103131 |
Appl. No.: |
17/003251 |
Filed: |
August 26, 2020 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
63002635 |
Mar 31, 2020 |
|
|
|
62895940 |
Sep 4, 2019 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61K 31/485 20130101;
G16H 10/65 20180101; G16H 20/70 20180101; A61K 9/0024 20130101;
A61K 9/16 20130101; G16H 30/00 20180101; G16H 40/67 20180101 |
International
Class: |
A61K 9/16 20060101
A61K009/16; G16H 20/70 20180101 G16H020/70; G16H 10/65 20180101
G16H010/65; A61K 9/00 20060101 A61K009/00; G16H 30/00 20180101
G16H030/00; G16H 40/67 20180101 G16H040/67; A61K 31/485 20060101
A61K031/485 |
Claims
1. A medical treatment delivery system of subcutaneous implant of
micro-pellets having medicine for release over time.
2. The medical treatment delivery system of claim 1, wherein the
micro-pellets are smaller than 11 mm in length.
3. The medical treatment delivery system of claim 1, wherein the
micro-pellets are implanted in a horizontal orientation parallel to
Langer lines in the horizontal plane surrounding the upper hips and
lower back.
4. The medical treatment delivery system of claim 1, wherein the
medicine is a class of drugs known as opiate antagonists.
5. The medical treatment delivery system of claim 1, wherein the
medicine is Naltrexone.
6. The medical treatment delivery system of claim 1, wherein the
medicine is Naltrexone combined with stearic acid.
7. The medical treatment delivery system of claim 1, wherein the
micro-pellets release the medicine over a period of approximately
three months.
8. The medical treatment delivery system of claim 1, wherein the
subcutaneous implant of micro-pellets includes the implant of an
RFID microchip.
9. A medical treatment method, which includes: subcutaneous
implanting into a patient micro-pellets having medication therein
which releases over time; and employing an identification device
into the patient wherein identification is enabled over the
Internet to a secure database associated with medical record and
treatment plan data for the identification device of the
patient.
10. A medical treatment method of claim 9, wherein the method of
identification is an RFID microchip, and an interrogator for
reading the RFID microchip and which is positioned at an access
point to a video conference system that has an internet connection
to the database with the patient's medical records and treatment
plan data.
11. A medical treatment method of claim 10, wherein the
interrogator is positioned in a back of a chair in which the
patient sits.
12. A medical treatment method of claim 9, wherein the video
conference system incorporates a two-way mirror between the patient
and an image display device positioned for providing the patient
with a direct view looking forward at eye level through the two-way
mirror at a displayed image on the image display while the two way
mirror is angled at approximately 45 degree to reflect an
illuminated panel that is positioned further from the two-way
mirror than the image display device.
13. A medical treatment method of claim 12, wherein a caregiver at
a distant location from the patient is captured by a camera with a
display system that achieves a line of sight directly toward the
camera and the video image and audio is transmitted over an
Internet connection to the location of the patient for appearing on
the image display with a perceived eye contact.
14. A medical treatment method of claim 12, wherein stored digital
files of a recorded video of a caregiver or a live computer
generated image of an avatar is transmitted to appear on the image
display device for viewing by the patient.
15. A medical treatment method of claim 12, wherein a camera is
positioned to view the patient as a reflection off the two-way
mirror along a line at eye level of the displayed image of a
transmitted person appearing on the image display device.
16. A medical treatment method of claim 15, wherein the camera
captures a digital image, video file or facial recognition
documentation of the patient to be stored in medical records of the
patient for identification for approval for usage of the video
conference system for the duration of a treatment plan.
17. A medical treatment method of claim 15, wherein the camera
captures a live video image of the patient that is analyzed by a
facial recognition application that identifies facial expressions
to determine the mental state of the patient.
18. A medical treatment method of claim 12, wherein a microphone
captures an audio recording of the patient to be stored in medical
records of the patient for identification for approval for usage of
the video conference system for the duration of a treatment plan.
Description
TECHNICAL FIELD
[0001] This present invention relates to treatment systems and
methods addressing multiple aspects to provide a comprehensive
recovery program for addictions, chronic conditions and
diseases.
BACKGROUND
[0002] It is well known that drug and alcohol addiction have
negative consequences in people's lives and affects the
productivity of our society. Furthermore, there are autoimmune
diseases, such as Grave's disease, lupus, and multiple sclerosis,
that require extensive care programs. There are many treatment
systems and methods available, however there is a need for a
comprehensive program that improves effectiveness and results in
saving lives, reducing suffering in the ones addicted, the family
and the extended community.
[0003] The Substance Abuse and Mental Health Services
Administration, the US Surgeon General, the National Institute on
Drug Abuse, and the Centers for Disease Control and Prevention have
a substantial body of research evidence supporting treatment with
buprenorphine or methadone, which have been demonstrated to be
highly effective in managing the core symptoms of opioid use
disorder, reducing the risk of relapse and fatal overdose, and
encouraging long-term recovery. However, buprenorphine or methadone
are substitutes for illicit drugs and may not overcome the root
causes of addiction or chronic condition.
[0004] Alternatively, Naltrexone belongs to a class of drugs known
as opiate antagonists, which works in the brain to prevent opiate
effects (e.g. feelings of well-being, pain relief). It also
decreases the desire to take opiates. This medication is also used
to treat alcohol abuse and chronic conditions.
[0005] The typical treatment method for buprenorphine, methadone
and Naltrexone is prescribed pills to be taken daily. This method
has poor results with compliance since the addicts may not take the
pills every day in an attempt to avoid the cost of further
prescriptions, or they simply forget to take the medication each
day as prescribed.
[0006] Another problem is that addicts may take excessive amounts
of pills at one time. This problem may be addressed by requiring
the addict to go to a dispensary each day to receive the prescribed
amount of medication. This presents a challenge for addicts to get
transportation to the clinic every day.
[0007] Another problem is that addicts may receive the pills
through a recovery program but sell them to other addicts to
receive money for the purchase of heroin or other illicit drugs. In
some cases, they may deliberately avoid taking the opiate
antagonists, which prevent opiate effects, in order to get the high
that they crave from illicit drugs.
[0008] The problems associated with treatments based on delivery of
medication in pill form have been addressed by an extended-release
injectable suspension. By way of example, one commercially
available treatment method is Vivitrol, which is based on a
Naltrexone formulation for deep injection containing 380 mg of the
medication per vial. The extended-release injections of Vivitrol
provide treatment for 21 to 30 days. However, these injections may
cause severe reactions at the site of injection. Some people on
Vivitrol have had severe injection site reactions, including tissue
death. Some of these reactions have required surgery. This Vivitrol
method incurs a major financial commitment in that the Vivitrol
injections may cost $1,600 or more per month compared to the
wholesale cost of Naltrexone in pill form that may be approximately
$24 per month.
[0009] Another more recently developed system is the delivery of
Naltrexone in medication pellets that get inserted under the skin
for slowly releasing the medication over varying lengths of
time--usually from 2 to 6 months. In one system of subcutaneous
implantation a 1'' long pellet is surgically implanted in an
incision requiring stitches. The implant is typically placed under
the skin in the area of the abdomen where it has the undesirable
result of a visible bulge with stitches. The implementations to
date are primarily experimental and investigational.
[0010] For motivated users who are committed to abstinence, the
Naltrexone implant may lower the risk of a relapse by reducing the
craving for opioids. In combination with therapy and behavioral
modification, Naltrexone can help reduce the desire for drugs.
While it is a helpful treatment tool, Naltrexone doesn't "cure"
opiate addiction, and the drug won't be effective unless the Client
is motivated to recover.
[0011] In addition to the need for a comprehensive recovery program
for addictions, there is a need for an improved treatment program
for autoimmune diseases. These conditions require the delivery of
medication to the patient in a controlled manner over an extended
period of time. Over time, various published articles have begun
suggesting that a Naltrexone regiment might prove to be helpful to
some clients who exhibit autoimmune diseases.
[0012] There is a need for a more cost-effective system for
administering medication for addiction and non-addiction treatment.
Furthermore, there is a need for a more comprehensive program that
addresses the need for counseling throughout the recovery process.
Hence, there is a need for an improved system that addresses the
shortcomings of the prior art mentioned above.
Prior Art Configurations
[0013] Previous systems and methods have been used for addiction
recovery treatment.
[0014] In FIG. 1 the primary method for treatment addiction is with
the prescription of medication in a pill form. In the field of
addiction treatment, a person participating in a recovery program
may be called a Client. In this method the Client 1 initially has a
line of communication 5 with an authorized clinic or hospital to
undergo an exam 2. As a requirement for medical treatment, the
Client 1 must establish a line of communication 8 with a financial
method of payment 4, which may be an insurance company, government
agency or private payment arrangement. This financial payment
method 4 must have a line of communication 9 to the provider of the
exam 2.
[0015] Upon completing the exam 2 a line of communication 6 is made
with a pharmacy or provider of medication 3 to place an order for
pills. The pharmacy must make the line of communication 10 with the
financial arrangement 4 for purchase of the pills. The Client 1
must have a line of communication 7 for the delivery of the pills
or physically travel to the provider 3 of the pills.
[0016] The primary problem with this method of treatment is the
results in compliance of the Client taking the pills as prescribed.
The Client 1 may not remember to take the prescribed pills as
needed. Also, the Client 1 may sell the drugs to generate money for
the purchase of illicit drugs. Furthermore, there is not an
effective method for confirming the identity of the Client 1 as
they may not have a permanent address or may not have a driver's
license or other identification documentation. This lack of
confirmation of identity leaves financial transactions open for
fraud, which has been a problem with government funded
programs.
[0017] In FIG. 2 the Client 1 established a line of communication 5
for an exam 2 at an authorized medical institution. The Client 1
contacts 8 a financial entity 4 for payment 9 for the exam 2. In
this method the exam 2 communicates 12 with a provider for an
injection 11. The Client 1 travels 13 to the provider for the
injection 11 and communicates 14 a method of payment 4.
[0018] In this method the Client 1 must return every month for
another injection 11. This method overcomes the problems of
treatment with pills since the Client 1 has a confirmed treatment
for a month. However, there are documented negative side effects
from the injection 11. Furthermore, the cost of injections is
substantially more expensive than treatment with pills.
[0019] In FIG. 3 the Client 1 has a line of communication 5 with a
provider for an exam 2. A communication 16 is sent to schedule an
implant 15. The Client 1 travels 17 to the medical facility for the
implant 15. The Exam facility 2 communicates 9 for the exam payment
at the financial entity 4. The financial entity 4 communicates 18
for the payment for the implant 15.
[0020] The implant may be a pellet with drugs known as opiate
antagonists. The injections may diminish craving for opiates or
alcohol. This injection may be Naltrexone or other drugs to address
addiction or other medical problems. However, it is well documented
that the administration of drugs is only one part of a recovery
program.
[0021] In FIG. 4 a more complete treatment program is shown. In
this example, the method of administering an implant 15 is
described. The addition of treatment 20 is added along a line of
communication 22 and a payment method 23. This treatment 20 may
involve a number of medical evaluations and processes to maintain
the health of the Client 1 during the recovery period that may be
12 months or more. Furthermore, in this more comprehensive program
counseling 21 is established along a line of communication 25 with
payment 24 with the financial 4 arrangement. The need for ongoing
treatment 20 and counseling 21 is well documented. However, a
comprehensive program is not commonly achieved due to the
challenges of establishing relationships with all of the different
professional services and the complexity of funding the
services.
SUMMARY OF THE INVENTION
[0022] It is an object to improve treatment for individuals
addictions, chronic conditions and diseases.
[0023] It is a further object to provide a medical treatment
delivery system using a subcutaneous implant of micro-pellets with
medicine for release over time.
[0024] A further object is to provide a medical treatment by
implanting in a medical delivery system along Langer lines in the
horizontal plane surrounding the upper hips and lower back.
[0025] Another object is to provide a treatment to aid in
combatting opiate addiction.
[0026] Still another object is to utilize a medicine, such as
Naltrexone combined with stearic acid, to treat addictions, chronic
conditions and diseases.
[0027] Yet another object is to provide medical treatment delivery
system using micro-pellets to release the medicine over a period,
such as several months.
[0028] A further object is to track the medicine by employing a
tracking device therewith.
[0029] Still another object is to read the tracking device when
positioned at an access point to a video conference system that has
an internet connection to the database with the Client's medical
records and treatment plan documentation.
[0030] A further object is to provide a video conference system
which incorporates a two-way mirror between the Client and an image
display device positioned for providing the Client with a direct
view looking forward at eye level through the two-way mirror at a
displayed image on the image display while the two-way mirror is
angled at approximately 45 degree to reflect an illuminated panel
that is positioned further from the two-way mirror than the image
display device and a caregiver at a distant location from the
Client is captured by a camera with a display system that achieves
a line of sight directly toward the camera and the video image and
audio is transmitted over an Internet connection to the location of
the Client for appearing on the image display with a perceived eye
contact.
[0031] A further object is to provide a live computer generated
image of an avatar through the system to appear on the image
display device for viewing by the Client.
[0032] Yet another object is to employ facial recognition that
identifies facial expressions to determine the mental state of the
Client.
[0033] Another object is to identify the Client using facial
recognition.
[0034] Still other objects employ recording mechanisms regarding
the treatment.
[0035] The problems and needs outlined above are addressed by
preferred embodiments of this present invention. For the purposes
of providing a definition of the overall scope and comprehensive
aspects of this present invention, it has been coined by the
inventors as the "Delaney Method" in honor of Pastor Greg Delaney
who has dedicated his life befriending the friendless . . . those
in desperate need of recovery. Unlike other systems and methods
that only address medical and physical concerns, the Delaney Method
addresses the whole person in their need for psychological and
emotional support. This specification will describe how the Delaney
Method may provide an innovative way to connect Clients with a
network of medical professionals, psychologists, and dedicated,
compassionate people who care about the wellbeing of their Clients'
lives.
[0036] It is well known that treatment of addiction is a challenge
for individuals to overcome. It requires the individual to have the
emotional commitment for changing their priorities to support the
recovery program. In particular, the Clients may have been badly
damaged by life's circumstances having become addicted to drugs
and/or alcohol. They may succumb to such a low state of health they
can barely muster a call for help or possibly can't envision help.
These ones may be stripped of life itself, have no reserves and
have no reasons to try living again. It is the aspiration of this
present invention to provide a method for intersecting with and
advocating for these helpless persons.
[0037] Addiction affects people in their lives to the core of their
existence. The journey in recovery may require finding a new
meaning of life. The transformation may involve a religious
experience to find a way forward beyond the abyss of addiction. For
some people, the teachings of Christianity may provide the
guidance. However, no matter what religion or beliefs may provide
the foundation for their lives, addicts need to reach into their
souls to commit to recovery.
[0038] The Delaney Method acknowledges this personal challenge and
provides the process and capability to achieve successful recovery.
This method utilizes an innovative communications technology to
connect Clients with supportive professionals who provide
compassion and understanding. Instead of the traditional recovery
treatment methods that require Clients to interact with staff at
hospitals and clinics, the Delaney Method provides face-to-face
counseling and supportive consultation through live video
communication. Whereas typical video communication is a display of
a person on a flat screen appearing from a remote location, the
Delaney Method is delivered with a patented communications
technology, called Holographical Reality, where a transmitted
person appears life-size three dimensionally in front of the Client
with eye contact for a natural human interaction. The Client does
not need to wear 3D glasses or a virtual reality headset.
[0039] The advantage of Holographical Reality compared to video
conferencing is that the sense of presence and personal connection
with eye contact establishes a feeling of trust in the honest
compassion and belief in caring that is essential for reaching into
the depth of the emotional soul of the Client as they struggle with
the challenges of overcoming addiction.
[0040] The practical advantage of Holographical Reality is that the
professionals delivering the treatment of the Delaney Method can
reach out to their Clients over a distance. This overcomes the
widespread problem of limited availability of Doctors, clinicians
and psychiatrists with the training to provide treatment for
addicts. In particular, the Clients may live in areas where there
are no such professionals in close proximity.
[0041] For the purposes of description for this present invention
Holographical Reality communication will be delivered in a suite of
furniture and equipment, called the "Omni-Carriage". The
Omni-Carriage will provide a chair for the Client and table between
the Client and the teleported professional caregiver appearing
life-size three dimensionally across the table from the Client
while making eye contact during two-way communication in real
time.
[0042] This Omni-Carriage will be networked to the servers of the
national or international database, called an "Omni-Server".
[0043] In the Delaney Method a Client may go to a physical location
of a building or suite of offices, called an "Omni-Portal", that is
equipped with one or more Omni-Carriages with a network connection
to the Omni-Server to manage the advanced video communication, A
new Client will be greeted by a staff member or an Omni-Avatar for
an introduction to the treatment program. An Omni-Avatar is video
or a computer generated lifelike image of a staff member that is
displayed as a life-size, three dimensional image on a
Holographical Reality system. The Omni-Avatar will respond to
sensors that may include motion sensors, proximity sensors, video
recognition, voice recognition, and/or other methods of recognizing
a person's presence and interaction. The sensors will trigger
responses from the Omni-Avatar, which may be a preprogrammed series
of video segments based on responses by the Client or may be based
on the logic of an Artificial Intelligence program to generate live
computer generated responses by the Omni-Avatar. A staff member or
the Omni-Avatar will take the basic information for enrollment,
however, professionally qualified Doctors and psychiatrists will
conduct the Client evaluation over a distance using Holographical
Reality.
[0044] In accordance with one embodiment of the present invention,
the method of administering a pellet with a medication is further
refined with a system based on "micro-pellets". This system is an
innovative step in that it overcomes the problems associated with
the present embodiment of pellets with medication and their
insertion.
[0045] The micro-pellets, which are smaller than a grain of rice,
do not require a surgical incision with the resulting need for
stitches. The micro-pellets are injected beneath the skin without
the need for surgery. The site of the injection recovers within one
or two days and does not leave a scar. With the administration of a
local numbing agent, the Client will not feel pain during the ten
minute procedure.
[0046] A first implementation may include four micro-pellets that
may be 250 mg each. These may be spaced a quarter of an inch or
more apart. With this system of proprietary micro-pellets, the
Client may receive a slow release of the medication over a duration
of 90 days. The comprehensive program of this present invention may
have a one year protocol. Following 90 days a second insertion may
include 3 micro-pellets for 750 mg of medication. This may be
followed with a third insertion of 2 micro-pellets for 500 mg and a
fourth insertion of 1 micro-pellet for 250 mg.
[0047] In the system of the present invention the insertion may be
positioned along "Langer Lines". These Langer Lines are defined by
the integral grain of the skin, which is aligned to allow for
stretching in the direction of movement surrounding the body. In
this embodiment the selected Langer Lines may be along the
horizontal alignment surrounding the hip along the beltline,
namely, between and parallel with the Langer Lines. The specific
location of insertion may be along this horizontal Langer Line at
the back portion of the body. In order to minimize the sensation of
awareness of the insertion within individuals, a right handed
person may have the insertion in the left portion of the back.
Conversely, a left handed person may have the insertion in the
right portion of the back.
[0048] The micro-pellets may be a proprietary formulation of
medication for the addictive or non-addictive treatment. For drug
addiction the medication may include stearic acid that will support
the effective medical delivery of the opiate antagonist medication
over a 90 day period. For autoimmune diseases the medication may be
specific to the disease.
[0049] An essential aspect of the method of the present invention
is the identification of the Client. In particular, the system of
implanting micro-pellets provides effective delivery of medication
over an extended period of time, but the implant is only one part
of the comprehensive treatment program. The present method includes
a program of medical treatments and counseling by accredited
therapists. This requires that the Client has a method for
identification with access to the medical records for the treatment
program.
[0050] Upon admission to a treatment program, a Client may receive
an identification card with a method of reading the Client
identity, such as a magnetic strip, ID chip, QR code or other
technology for retrieving information. This card may be used upon
the return of the Client to a medical treatment location. However,
it would be advantageous to have an additional method of
identification since the Client may lose the card or forget to
bring it to an appointment.
[0051] At an initial medical exam, the Client may be able to prove
his or her identity. However, during a treatment period that may
have a duration of twelve months, they may not retain the identity
card. In the case of an incident needing medical attention, the
Client could suffer serious consequences or even death if there is
not a way to quickly confirm the contents of their imbedded
medication.
[0052] Clients with alcohol or drug addiction may not have standard
forms of identification, such as a driver's license. They may not
have a permanent address. It may be that these Clients do not have
medical insurance cards since they may not have any form of
insurance. While they may remember their social security number,
the confirmation of their identity may be difficult considering
their addictive condition. The Client could be given identifying
codes or passwords, but these may be forgotten. They may start
their treatment at one clinic but over the duration of the
treatment program they may move to another city or another
state.
[0053] Therefore, it is important to be able to prove the identity
of the Client through the duration of the treatment program. The
preferred method of identification is to avoid a manual process of
reviewing paperwork or manually logging into various databases to
access information that can be both time consuming and unreliable.
It is thus another objective of this present invention to implement
identification methods that are both instantaneous and automated to
initiate video communication programs and live video communications
that are specific to the Client at the appropriate stage of their
treatment program. This Delaney Method may quickly and efficiently
identify the Client to receive the treatment services of their
program without needing to fill out any paperwork upon arriving at
any Omni-Portal.
[0054] In another embodiment of the present invention the
Omni-Carriage will facilitate one or more methods for
identification.
[0055] A camera, as an integral component of the Omni-Carriage,
will capture an image of the Client seated in a position for a
counseling session. A high definition digital photo and/or a video
segment may be captured to be stored within the database of the
Omni-Server where it will be saved in the medical records of the
Client. Upon the initiation of a counseling session, the digital
photo or video may be used to identify the Client. In a further
method of identification, a microphone as an integral component of
the Omni-Carriage may capture an audio recording of the Client to
be stored at the database of the Omni-Server for identification by
voice recognition.
[0056] Additionally, a facial recognition system may be integrated
into the Omni-Carriage for the purpose of providing an accurate
identity of the Client. In a further method of identification, a
significant and yet non-obvious embodiment of this present
invention is the insertion of a Radio Frequency Identification
Device at the time of the first insertion of the micro-pellets. In
this system the selected RFID microchip may be smaller than a grain
of rice. It would be inserted in a similar method as the
micro-pellets and would be inserted at the same time as the
procedure for the micro-pellets with medication. This would not
require any significant additional time for the procedure and would
not impose an additional inconvenience upon the Client.
[0057] An Omni-Carriage may incorporate an interrogator scanning
device to instantly read the code within the microchip, which may
be linked to a computer within the Omni-Carriage that is networked
to the Omni-Portal for identification of the Client. The
interrogator may be integrated in the back of the chair within the
Omni-Carriage to be positioned within 10 cm (4'') of the placement
of the microchip in the back of the Client.
[0058] In this embodiment the RFID microchip would be passive in
that it would not have a battery or any internal power source. In
this regard, it would be completely inert. The microchip would
never wear down and could be good for the lifetime of the Client.
The specified RFID may be glass encapsulated so that it is
biocompatible. This means that it would be non-toxic and would not
have any allergic reaction or other adverse effect on the human
body.
[0059] The microchip may include a cap made of polypropylene
polymer to keep the chip from moving around once it is inserted.
The polymer works by encouraging connective tissue and other kinds
of cells to form around the capsule to hold it in place.
[0060] Inside the capsule is a silicon microchip, a tuning
capacitor and an antenna coil. In order to retrieve the information
on the microchip an interrogator performs the function of
energizing the antenna coil to activate the capacitor to read the
microchip. When set at the specified frequency the interrogator
scans the microchip to receive an identification number.
[0061] It is important to note that the microchip only provides an
identification number, which does not reveal any personal
information about the Client. This ID number is only meaningful
when used as identification within an external database. In this
regard the application of an RFID microchip meets all HIPAA privacy
requirements for confidential medical information or any other
privacy requirements. Furthermore, the microchip can be simply
removed by a small incision at any time during the treatment or
following the completion of the treatment program.
[0062] The comprehensive treatment system of this present invention
based on an implanted microchip establishes a platform for the
delivery of an extensive host of innovations in the care for
Clients needing addiction recovery treatment that has not been
possible with previous systems. The simple ID number establishes a
link to a database accessed over the Internet for the full scope of
innovative services.
[0063] While it is important to confirm identity, it is essential
that the Client's medical records are confidential. Clients may not
want information about an addiction recovery program on their
personal record. For these reasons it would be undesirable for the
identity of the Client to be recorded by permanent physical
methods, such as fingerprints, iris scans or tattoos.
[0064] The identification method of this present method using a
microchip solves the problems presented above. The microchip does
not contain any confidential information since it only retains a
single identification number. Furthermore, the microchip is not
physically visible when inserted and can be removed at any time
during or after the treatment program.
[0065] One of the unique benefits of the method using a microchip
is that a Client could undergo a treatment program without ever
revealing any of their personal information. This may be of extreme
importance for individuals who need addiction recovery treatment,
but do not want their condition to be known to their employers,
insurance providers or other people. These anonymous individuals
could undergo their exam for confirmation of their medical
condition and pay for their treatment in cash. They could receive
the insertion of the micro-pellets and microchip for the treatment.
For the duration of the program they would only need to provide
access to the code on their microchip to continue with all aspects
of treatment.
[0066] Another aspect of the present invention is that the method
of using visual recognition, voice recognition or a microchip for
identification would eliminate the liability of fraud during
treatment. The Client could not sell the treatment services to
another individual or claim treatment that was not delivered since
their identity is confirmed. It may be of particular value to
government funded programs where confirmation of services can be
validated for recipients.
[0067] Further advantages of the above described methods of
identity verification may be evident during the treatment period.
As the Clients proceed with the program of medical procedures and
counseling, the identity will need to be verified multiple times.
If the Client is in a poor cognitive state during drug or alcohol
recovery their ability to communicate effectively may be
compromised. Also, the Client may be of a different nationality and
may not have command of the English language to establish their
identity.
[0068] Once the Client is identified at an Omni-Carriage, the
Omni-Sever database is triggered to initiate the current program
for the Client. This may be a pre-programmed video content that
will appear in the Omni-Carriage as a Holographical Reality
display. This content may be a video image of person welcoming the
Client upon their return for treatment. The selection of the video
content may be determined by a sophisticated Artificial
Intelligence (AI) program that will present a communication
response that is uniquely appropriate for the Client. The AI
response may be a selected pre-recorded video of a caregiver
welcoming the Client back. Alternatively, the video may be a real
time, computer generated avatar appearing life-size in a highly
realistic human embodiment. In this modality, the same avatar that
previously greeted and met with the Client will reappear
essentially providing comfort (through continuity) that the same
doctor is bedside or in the room with the Client.
[0069] The Omni-Carriage includes a high definition camera to
capture a video image that is transmitted to be viewed by the
caregiver for live two-way communication. This same video image may
be analyzed by a computer for AI evaluation of facial recognition
that may provide information about the emotional state of the
Client. The combination of the information in the medical records
within the Omni-Server on the Client and their AI evaluation of
their condition will determine the assignment of the appropriate
caregiver to be teleported to the Omni-Carriage.
[0070] It is the strategy of the present invention to develop a
network of thousands of Omni-Portals equipped with Omni-Carriages
for Clients to access within a reasonable driving distance. The
caregivers will be logged into the Omni-Server over a network to be
available for transmission to Omni-Carriages. In cases where the
Clients have scheduled follow-up meetings, the Client will go to
the nearest Omni-Portal for the scheduled session with the assigned
caregiver for their treatment. There would not be a need to return
to the location at the beginning of the treatment, since each
Omni-Carriage at any location in the country would access the same
Omni-Server database and resource of caregivers for live video
communication. In this way services can be delivered without the
limitations of geographic proximity. If there is a need for the
Client to make contact to a caregiver for an unscheduled time, the
next available caregiver will be teleported to the Omni-Carriage
for meeting with the Client.
[0071] The network of locations may expand as the organization has
the resources to install thousands of Omni-Carriages throughout the
United States in counties, cities, towns and townships. One
preferred method for this expansion is to incorporate an
Omni-Carriage within a self-contained module. The term "module" can
be related to the association with the "lunar module" used for the
enclosure for the astronauts during the trip to the moon. In this
context, an "Omni-Module" could be the enclosure for an
Omni-Carriage where a Client would be teleported to another part of
the country or another part of the world. An Omni-Module may be no
larger than the size needed for an Omni-Carriage system with
seating to accommodate a Client for a Holographical Reality
experience with a caregiver being teleported from another location.
The size of the footprint of the Omni-Module may be approximately
5' wide and 7' long.
[0072] The Omni-Module may not have windows or openings that would
allow visual access from the outside. Furthermore, the Omni-Module
may contain the audio of the communication within the enclosure by
the means of construction and acoustic treatment so that the voices
of the participants cannot be heard outside. In order to further
assure that the voices of the participants are not recognizable
from outside of the room a generator of white noise may be used to
mask the voices.
[0073] An Omni-Module will be small enough that it could be set in
available spaces in community centers, churches, local government
facilities, etc. Furthermore, it could be licensed to be installed
within commercial venues, such as Walmart, CVS, Walgreens, etc.
With a national network in the United States, Clients could go to
any Omni-Module to have their caregiver teleported to meet with
them.
[0074] An Omni-Module would have an identification method to
authorize entry by a Client without any staff at that location. The
identification may be by an issued ID card, facial recognition,
voice recognition, RFID chip or other approved identity method.
With approval of identity of a Client the door to the Omni-Module
would be unlocked and the Omni-Server database would be instantly
retrieved for the Client. Upon entering the Omni-Module the
Holographical Reality visual and audio content would be initiated.
One of the advantages of Omni-Modules is that the Clients could
gain access to addiction services even in locations where there are
not medical staff present or caregivers within hundreds of miles. A
further advantage of Omni-Modules is that Clients could seek help
without revealing to people in their community that they have
addiction problems. In traditional methods of treatment the addicts
need to meet with staff members of the treatment facilities in
their own community for care. As a result, many addicts may not
seek treatment due to their fear of being recognized during
treatment and risk being outcast within their community.
[0075] A rollout of thousands of Omni-Portals and Omni-Modules
could be through franchises to healthcare corporations, national
pharmacies, stores, investors, etc.
[0076] The Delaney Method has the potential of helping people
worldwide with the ability to deliver care remotely.
[0077] The Delaney Method may be licensed to governments or
healthcare services of other countries and franchisees in any
country. The principles of the Omni-Portal, Omni-Carriage,
Omni-Server and Omni-Module may remain the same on a global
scale.
[0078] However, the implementation in each country may be managed
in the language of the country and operated within the regulations
for insurance and legal requirements of their government managed
through a Global Server.
BRIEF DESCRIPTION OF THE DRAWINGS
[0079] The above features of the present invention will be more
clearly understood from consideration of the following descriptions
in connection with accompanying drawings in which:
[0080] FIG. 1 illustrates a prior art configuration of treatment
based on medication in a pill format.
[0081] FIG. 2 illustrates a prior art configuration of treatment
based on medication administered in an injection.
[0082] FIG. 3 illustrates a prior art configuration of treatment
based on a subcutaneous implantation of a pellet comprised of
medication.
[0083] FIG. 4 illustrates a prior art configuration of a
comprehensive program including medical treatment and counseling
during the recovery period.
[0084] FIG. 5 illustrates a method of the present invention with a
portal that is central to all the supporting aspects for a
comprehensive recovery program.
[0085] FIG. 6 illustrates an implementation of the method of this
present invention that provides a Client with a treatment module
through a method of identification to access an advanced video
communication system with a networked portal for delivery of
generated video content and live video communication for their
treatment program.
[0086] FIG. 7 illustrates an implementation of the present
invention that may include a large number of locations for Clients
to connect through a server with a large resource of healthcare
services
[0087] FIG. 8 illustrates an implementation of the present
invention with a number of large networked to service organizations
managed through a global server.
[0088] FIG. 9 is a depiction of Langer lines in a human.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0089] Referring now to the drawings, wherein like reference
numbers are used to designate like elements throughout the various
views, several embodiments are further described. One of ordinary
skill in the art will appreciate the many possible applications
based on the following examples of possible embodiments.
[0090] FIG. 5 shows an embodiment of the present invention with a
Client 1 making a connection 30 with a treatment facility called an
Omni-Portal 31. The Omni-Portal 31 may be a free-standing building
or a suite of offices that is equipped with one or more
Holographical Reality systems that is networked with an Omni-Server
101 to manage the advanced video communication. A staff member or
an Omni-Avatar 60 will provide an introduction to the treatment
program. An Omni-Avatar 60 is video or a computer generated
lifelike image of a staff member that is a life-size, three
dimensional embodiment displayed in Holographical Reality on an
Omni-Carriage. The Omni-Avatar 60 will respond to sensors 62 that
may include motion sensors, proximity sensors, video recognition,
voice recognition, and/or other methods of recognizing a person's
presence and interaction. The sensors will respond to the actions
of the Client 1 to activate the Omni-Avatar 60 to welcome them to
the Omni-Portal 31 and proceed to gather basic information for
enrollment. The Omni-Avatar 60 may respond with a series of
pre-recorded video segments of an actual person or may respond with
a live computer generated lifelike image based on the logic of an
Artificial Intelligence "AI" program.
[0091] Once a staff member or the Omni-Avatar 60 has taken the
basic information for enrollment, professionally qualified Doctors
and psychiatrists will conduct the Client 1 evaluation over a
distance using Holographical Reality. At the Omni-Portal 31
communication 32 may be established for the Client 1 to have an
exam 33. At the Omni-Portal 31 a staff member or an automated
process will communicate 41 to make financial arrangements 40 for
the Client 1 to have treatment. These financial arrangements 40 may
be Medicare, Medicaid, insurance, private pay or other payment
methods. The medical results of the exam 33 and the financial 40
information will be uploaded to the Omni-Server 101 at a national
or international data center for access by the Omni-Portal 31. A
treatment program will be scheduled that will be delivered under
the process called the Delaney Method.
[0092] Following the Exam 33 the staff at the Omni-Portal 31 will
communicate 35 with the certified staff to proceed with an implant
34 for the Client 1. The implant 34 may be comprised of
"micro-pellets" 64, which is an innovative step that overcomes the
problems associated with the present embodiment of larger pellets
with medication and their insertion. The micro-pellets 64 are
configured preferably smaller than a grain of rice, which therefore
do not require a surgical incision with the resulting need for
stitches. The micro-pellets 64 are injected beneath the skin
without the need for surgery. The site of the injection recovers
within one or two days and does not leave a scar. With the
administration of a local numbing agent, the Client 1 will not feel
pain during the ten minute procedure.
[0093] A first implementation may include four micro-pellets 64
that may be 250 mg each. These may be spaced a quarter of an inch
or more apart. With this system of proprietary micro-pellets 64,
the Client 1 may receive a slow release of the medication over a
duration of 90 days.
[0094] The system of the present invention provides for the
insertion of the micro pellets 64 positioned along "Langer Lines"
defined by the integral grain of the skin, which is aligned to
allow for stretching in the direction of movement surrounding the
body. In this embodiment the selected Langer Lines may be along the
horizontal alignment surrounding the hip along the beltline,
namely, between and parallel with the Langer Lines. The specific
location of insertion may be along this horizontal Langer Line at
the back portion of the body. In order to minimize the sensation of
awareness of the insertion within individuals, a right handed
person may have the insertion in the left portion of the back.
Conversely, a left handed person may have the insertion in the
right portion of the back.
[0095] The micro-pellets 64 may be a proprietary formulation of
medication for the addictive or non-addictive treatment. For drug
addiction the medication may include stearic acid that will support
the effective medical delivery of the opiate antagonist medication
over a 90 day period. For autoimmune diseases the medication may be
specific to the disease.
[0096] Once the implant 34 is complete the Client 1 will receive
treatment 36 during the duration of the Delaney Method program.
This treatment 36 may be scheduled 37 at an Omni-Portal 31 for the
Client 1. One aspect of the treatment may be hydration 67, which is
a process of injecting the fluids needed to support successful
recovery during the program. At an attending physician's
prescription and instruction, immediately after each micro pellet
implantation and at a repeated cadence over time, there may be
offered to the patient and the patient might agree to receive
intravenous hydration 67. Most addicts are woefully dehydrated. For
the Micro Pellets to dissolve evenly over time, each patient might
need hydration 67.
[0097] Also, during the program established in the Delaney Method
the Omni-Portal 31 will establish communication 39 for counseling
38 for the Client 1. This may involve having the Client 1 come to
the Omni-Portal 31 to meet with a counselor in person or through
advanced live video communication.
[0098] FIG. 6 shows that a Client 1 may go to an unmanned enclosure
holding an advanced video communication system, called an
Omni-Module 102, during the duration of the treatment in the
Delaney Method. The term "module" can be related to the association
with the "lunarmodule" used for the enclosure for the astronauts
during the trip to the moon. In this context, an "Omni-Module" 102
could be the enclosure for an Omni-Carriage 104 where a Client 1
would be transmitted through Holographical Reality to another part
of the country or another part of the world. An Omni-Module 102 may
be no larger than the size needed for an Omni-Carriage 104 with
seating to accommodate a Client for a Holographical Reality
experience with a caregiver being transmitted from another
location. The size of the footprint of the Omni-Module 102 may be
approximately 5' wide and 7' long. The Omni-Module 102 may not have
windows or openings that would allow visual access from the
outside. Furthermore, the Omni-Module 102 may contain the audio of
the communication within the enclosure by the means of construction
and acoustic treatment so that the voices of the participants
cannot be heard outside. In order to further assure that the voices
of the participants are not recognizable from outside of the room a
generator of white noise may be used to mask the voices. An
Omni-Module 102 will be small enough that it could be set in
available spaces in community centers, churches, local government
facilities, etc. Furthermore, it could be licensed to be installed
within commercial venues, such as Walmart, CVS, Walgreens, etc.
With a national network in the United States, Clients could go to
any Omni-Module 102 to have their caregiver teleported to meet with
them.
[0099] An Omni-Module 102 would have an identification method to
authorize entry by a Client 1 without any staff at that location.
The identification may be by an issued ID card, facial recognition,
voice recognition, RFID microchip 66 or other approved identity
method. With approval of identity of a Client 1, the door to the
Omni-Module 102 would be unlocked and the Omni-Server 101 database
would be instantly retrieved for the Client 1. Upon entering the
Omni-Module 102 the Holographical Reality visual and audio content
would be initiated. One of the advantages of Omni-Modules is that
the Clients could gain access to addiction services even in
locations where there are not medical staff present or caregivers
within hundreds of miles. A further advantage of Omni-Modules is
that Clients could seek help without revealing to people in their
community that they have addiction problems. In traditional methods
of treatment, the addicts need to meet with staff members of the
treatment facilities in their own community for care. As a result,
many addicts may not seek treatment due to their fear of being
recognized during treatment and risk being outcast within their
community.
[0100] The Client 1 may unlock the door to the Omni-Module 102
using a method of identification 103. The identification 103 will
also trigger the Omni-Server 101 of the network of Omni-Portals 31
to begin to deliver advanced video communication to a suite of
furniture and audio-visual equipment, called an Omni-Carriage 104.
It is through the Omni-Carriage 104 that the services of the
Omni-Portal 31 may be delivered through live, prerecorded and
computer generated advanced video communication.
[0101] An essential aspect of the method of the present invention
is the identification of the Client 1. In particular, the system of
implanting micro-pellets 64 provides effective delivery of
medication over an extended period of time, but the implant is only
one part of the comprehensive treatment program. The present method
includes a program of medical treatments and counseling by
accredited therapists. This requires that the Client 1 has a method
for identification with access to the medical records for the
treatment program.
[0102] Upon admission to a treatment program, a Client 1 may
receive an identification card with a method of reading the Client
identity, such as a magnetic strip, RFID microchip 66, QR code or
other technology for retrieving information. This card may be used
upon the return of the Client 1 to a medical treatment location.
However, it would be advantageous to have an additional method of
identification since the Client 1 may lose the card or forget to
bring it to an appointment.
[0103] At an initial medical exam, the Client 1 may be able to
prove his or her identity.
[0104] However, during a treatment period that may have a duration
of twelve months, they may not retain the identity card. In the
case of an incident needing medical attention, the Client could
suffer serious consequences or even death if there is not a way to
quickly confirm the contents of their imbedded medication.
[0105] Clients with alcohol or drug addiction may not have standard
forms of identification, such as a driver's license. They may not
have a permanent address. It may be that these Clients do not have
medical insurance cards since they may not have any form of
insurance. While they may remember their social security number,
the confirmation of their identity may be difficult considering
their addictive condition. The Client 1 could be given identifying
codes or passwords, but these may be forgotten. They may start
their treatment at one clinic but over the duration of the
treatment program they may move to another city or another
state.
[0106] Therefore, it is important to be able to prove the identity
of the Client through the duration of the treatment program. The
preferred method of identification is to avoid a manual process of
reviewing paperwork or manually logging into various databases to
access information that can be both time consuming and
unreliable.
[0107] It is thus another objective of this present invention to
implement identification methods that are both instantaneous and
automated to initiate video communication programs and live video
communications that are specific to the Client 1 at the appropriate
stage of their treatment program. This Delaney Method may quickly
and efficiently identify the Client to receive the treatment
services of their program without needing to fill out any paperwork
upon arriving at any Omni-Portal 31 or Omni-Module 102.
[0108] In another embodiment of the present invention a suite of
furniture with integrated audio-visual equipment configured to
deliver Holographical Reality communications between the Client and
professionals administering the treatment program and furthermore,
will facilitate one or more methods for identification. This
Omni-Carriage within an Omni-Portal will be networked to the
Omni-Server 101 of the national or international database of the
Omni-Portals 31. The Omni-Carriage will provide a chair for the
Client 1 and table between the Client 1 and the transmitted
professional caregiver appearing life-size three dimensionally
across the table from the Client while making eye contact during
two-way communication in real time. This suite of furniture and
equipment is the Omni-Carriage 104.
[0109] A camera, as an integral component of the Omni-Carriage 104,
will capture an image of the Client 1 seated in a position for a
counseling session. A high definition digital photo and/or a video
segment may be captured to be stored within the database of the
Omni-Portal where it will be saved in the medical records of the
Client 1. Upon the initiation of a counseling session, the digital
photo or video may be used to identify the Client 1. In a further
method of identification, a microphone as an integral component of
the Omni-Carriage 104 may capture an audio recording of the Client
1 to be stored at a database of the Omni-Server 101 of Omni-Portal
31 for identification by voice recognition.
[0110] Additionally, a facial recognition system may be integrated
into the Omni-Carriage 104 for the purpose of providing an accurate
identity of the Client 1. In a further method of identification, a
significant and yet non-obvious embodiment of this present
invention is the insertion of a Radio Frequency Identification
Device 66 at the time of the first insertion of the micro-pellets
64. In this system the selected RFID microchip 66 may be smaller
than a grain of rice. It would be inserted in a similar method as
the micro-pellets 64 and would be inserted at the same time as the
procedure for the micro-pellets 64 with medication. This would not
require any significant additional time for the procedure and would
not impose an additional inconvenience upon the Client 1.
[0111] An Omni-Carriage 104 may incorporate a scanning device,
called an interrogator 68, to instantly read the code within the
RFID microchip 66, which may be linked to a computer within the
Omni-Carriage 104 that is networked to the Omni-Portal 31 for
identification of the Client 1. The interrogator 68 may be
integrated in the back of the chair within the Omni-Carriage 104 to
be positioned within 10 cm (4'') of the placement of the RFID
microchip 66 in the back of the Client 1.
[0112] In this embodiment the RFID microchip device 66 would be
passive in that it would not have a battery or any internal power
source. In this regard, it would be completely inert. The RFID
microchip 66 would never wear down and could be good for the
lifetime of the Client 1. The specified RFID microchip 66 may be
glass encapsulated so that it is biocompatible. This means that it
would be non-toxic and would not have any allergic reaction or
other adverse effect on the human body.
[0113] The RFID microchip device 66 may include a cap made of
polypropylene polymer to keep the chip from moving around once it
is inserted. The polymer works by encouraging connective tissue and
other kinds of cells to form around the capsule to hold it in
place. Inside the capsule is a silicon microchip, a tuning
capacitor and an antenna coil. In order to retrieve the information
on the RFID microchip 66 an interrogator 68 performs the function
of energizing the antenna coil to activate the capacitor to read
the microchip. When set at the specified frequency the interrogator
68 scans the RFID microchip 66 to receive an identification
number.
[0114] It is important to note that the RFID microchip 66 only
provides an identification number, which does not reveal any
personal information about the Client. This ID number is only
meaningful when used as identification within an external database.
In this regard the application of an RFID microchip 66 meets all
HIPAA privacy requirements for confidential medical information or
any other privacy requirements. Furthermore, the RFID microchip
device 66 can be simply removed by a small incision at any time
during the treatment or following the completion of the treatment
program.
[0115] The comprehensive treatment system of this present invention
based on an implanted RFID microchip 66 establishes a platform for
the delivery of an extensive host of innovations in the care for
Clients needing addiction recovery treatment that has not been
possible with previous systems. The simple ID number establishes a
link to a database accessed over the Internet for the full scope of
innovative services.
[0116] While it is important to confirm identity, it is essential
that the Client's medical records are confidential. The
identification method of this present method using an RFID
microchip 66 solves the problems presented above. The RFID
microchip 66 does not contain any confidential information since it
only retains a single identification number. Furthermore, the RFID
microchip 66 is not physically visible when inserted and can be
removed at any time during or after the treatment program.
[0117] One of the unique benefits of the method using an RFID
microchip 66 is that a Client 1 could undergo a treatment program
without ever revealing any of their personal information. This may
be of extreme importance for individuals who need addiction
recovery treatment, but do not want their condition to be known to
their employers, insurance providers or other people. These
anonymous individuals could undergo their exam for confirmation of
their medical condition and pay for their treatment in cash. They
could receive the insertion of the micro-pellets 64 and RFID
microchip 66 for the treatment. For the duration of the program
they would only need to provide access to the code on their RFID
microchip 66 to continue with all aspects of treatment.
[0118] Another aspect of the present invention is that the method
of using visual recognition, voice recognition or an RFID microchip
66 for identification would eliminate the liability of fraud during
treatment. The Client 1 could not sell the treatment services to
another individual or claim treatment that was not delivered since
their identity is confirmed. It may be of particular value to
government funded programs where confirmation of services can be
validated for recipients.
[0119] Further advantages of the above described methods of
identity verification may be evident during the treatment period.
As the Clients 1 proceed with the program of medical procedures and
counseling, the identity will need to be verified multiple times.
If the Client 1 is in a poor cognitive state during drug or alcohol
recovery their ability to communicate effectively may be
compromised. Also, the Client 1 may be of a different nationality
and may not have command of the English language to establish their
identity.
[0120] Once the Client is identified at an Omni-Carriage 104, the
Omni-Server 101 is triggered to initiate the current program for
the Client 1. This may be a pre-programmed video content that will
appear in the Omni-Carriage 104 as a Holographical Reality display.
This content may be a video image of person welcoming the Client 1
upon their return for treatment. The selection of the video content
may be determined by a sophisticated Artificial Intelligence (AI)
program that will present a communication response that is uniquely
appropriate for the Client 1. The AI response may be a selected
pre-recorded video of a caregiver welcoming the Client back.
Alternatively, the video may be a real time, computer generated
Omni-Avatar 60 appearing life-size in a highly realistic human
embodiment. In this modality, the same Omni-Avatar 60 that
previously greeted and met with the Client 1 will reappear
essentially providing comfort (through continuity) that the same
doctor is bedside or in the room with the Client 1.
[0121] The Omni-Carriage 104 includes a high definition camera to
capture a video image that is transmitted to be viewed by the
caregiver for live two-way communication. This same video image may
be analyzed by a computer for AI evaluation of facial recognition
that may provide information about the emotional state of the
Client. The combination of the information in the medical records
within the Omni-Portal 31 on the Client 1 and their AI evaluation
of their condition will determine the assignment of the appropriate
caregiver to be teleported to the Omni-Carriage 104.
[0122] In FIG. 7 Clients may enter an Omni-Module gain access over
a network 200 to an Omni-Server 101 that would have their records
and progress for their recovery program of the Delany Method. This
Omni-Server 101 may initiate communication with service providers
at Omni-Portals 201. By virtue of the present invention, there can
be a network of thousands of Omni-Portals 31 with communications
capabilities for Clients to access caregivers. In cases where the
Clients have scheduled follow-up meetings, the Client will go to
the nearest Omni-Module 102 for the scheduled session with the
assigned caregiver for their treatment. There would not be a need
to return to the location at the beginning of the treatment, since
each Omni-Module 102 at any location would access the same
Omni-Server 101 database with the resource of caregivers for live
video communication. In this way services can be delivered without
the limitations of geographic proximity. If there is a need for the
Client to make contact to a caregiver for an unscheduled time, the
next available caregiver will be routed to the Omni-Module 102 for
meeting with the Client.
[0123] In FIG. 8 a Global Omni-Server 400 may be connected over a
high speed network 401 to Omni-Servers 101 supporting large or
national implementations of the Delany Method.
[0124] FIG. 9 shows an illustration of the back of a human body
with lines illustrating the Langer Lines 500 defined by the
integral gain of the skin. The micro-pellets of the present
invention are inserted in a horizontal orientation in the selected
Langer Lines 501 along the horizontal alignment surrounding the hip
along the beltline.
[0125] While the preferred embodiments of the present invention are
set forth above, these embodiments and the claims which follow are
to be construed with equivalents, modifications, improvements and
derivations. The claims are to be afforded the protection of such
equivalents, modifications, improvements and derivations.
[0126] What is claimed is:
* * * * *